Orion Pharma (UK) Limited

Oaklea Court, 22 Park Street, Newbury, Berkshire, RG14 1EA
Telephone: +44 (0)1635 520 300
Fax: +44 (0)1635 580 180
Medical Information e-mail: medicalinformation@orionpharma.com
Out of Hours Telephone: +44 (0)1635 520 300

Patient Information Leaflet last updated on the eMC: 31/03/2009
PIL Frusene

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 31/03/2009 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change due to user-testing of patient information
Updated on 06/11/2006 and displayed until 31/03/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 22/09/2006 and displayed until 06/11/2006
Reasons for adding or updating:
  • Change to date of revision
Updated on 13/08/2004 and displayed until 22/09/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to side-effects
Updated on 01/11/2002 and displayed until 13/08/2004
Reasons for adding or updating:
  • PIL Retired pending re-submission
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   triamterene
   furosemide